Lv1
58 积分 2025-08-04 加入
Monoacylglycerol Acyltransferase 2 (MGAT2) Inhibitors for the Treatment of Metabolic Diseases and Nonalcoholic Steatohepatitis (NASH)
16天前
已完结
SARM1 activation promotes axonal degeneration via a two-step phase transition
16天前
已完结
Targeting NRF2 to treat cancer
21天前
已完结
Thirty years of NRF2: advances and therapeutic challenges
21天前
已完结
The tumor suppressive role of KEAP1: Underlying mechanisms and therapeutic implications
21天前
已完结
NRF2 signalling: an emerging therapeutic target for Alzheimer’s disease
22天前
已完结
TNG961 is a selective oral HBS1L molecular glue degrader for the treatment of FOCAD-deleted cancers
25天前
已完结
The aryl hydrocarbon receptor: a rehabilitated target for therapeutic immune modulation
1个月前
已完结
Small molecules that targeting p53 Y220C protein: mechanisms, structures, and clinical advances in anti-tumor therapy
2个月前
已完结
HCN2 ion channels: an emerging role as the pacemakers of pain
2个月前
已完结
皖公网安备34019202002308
